Real-time enrollment status for this lymphoma, b-cell clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 12:25 AM UTC
| NCT Number | NCT06792734 |
| Recruiting Status | Recruiting |
| Condition | Lymphoma, B-Cell |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Bantam Pharmaceuticals |
| Last Updated on CT.gov | July 7, 2026 (Jul 7, 2026) |
As of August 28, 2026: Clinical trial NCT06792734 is currently recruiting participants. This phase1 study for lymphoma, b-cell is actively seeking new participants at 2 locations across the United States. The study is sponsored by Bantam Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06792734 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06792734 was last updated Jul 7, 2026 (July 7, 2026). HelloStudys verifies this status automatically.